Legend Biotech (LEGN) Director Corazon Sanders Sells 27,370 Shares

What Happened
Corazon (Corsee) D. Sanders, a director of Legend Biotech Corp (LEGN), disposed of 27,370 ordinary shares in an open-market sale on September 29, 2026. The filing reports a weighted average sale price of $9.46 per share for a total proceeds amounting to $258,920.

Key Details

• Transaction date: 2026-09-29 (sale; code S).
• Price: weighted average $9.46 per ordinary share; reported price range $9.445–$9.48 (footnote F2).
• Total reported proceeds: $258,920.
• Shares owned after the transaction: not disclosed in the Form 4 provided.
• Filing date: 2026-10-01 (filed within the usual two-business-day Form 4 window — timely).
• Notable footnotes:
  • F1: Ordinary shares may be represented by ADSs (1 ADS = 2 ordinary shares).
  • F2: The filing lists a weighted average price and a range; the reporting person will provide a breakdown of quantities at each price on request.

Context
This was a straight sale disposition (not an option exercise or gift). Sales by insiders can be routine (diversification, liquidity, tax needs) and do not necessarily signal a change in company outlook; purchases are generally more informative about insider sentiment. The filing appears timely, and no additional special plans (e.g., 10b5-1) or tax-withholding notes were disclosed.